These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 16399711)

  • 1. On Patient Safety: Mirroring the Strategies Used for Delivering COVID-19 Medications May Improve How Developing Countries Obtain Essential Medicines.
    Rickert J
    Clin Orthop Relat Res; 2021 Feb; 479(2):236-238. PubMed ID: 33273246
    [No Abstract]   [Full Text] [Related]  

  • 2. Human health implications of emerging diseases and the current situation in India's vaccine industry.
    Behera JK; Mishra P; Jena AK; Behera B; Bhattacharya M
    Sci One Health; 2023; 2():100046. PubMed ID: 39077045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stockpiling of raw material for oseltamivir is not justified.
    Bertelli AA
    BMJ; 2006 Jan; 332(7534):178. PubMed ID: 16424506
    [No Abstract]   [Full Text] [Related]  

  • 4. Roche considers licensing companies to make oseltamivir.
    Tanne JH
    BMJ; 2005 Oct; 331(7523):981. PubMed ID: 16254280
    [No Abstract]   [Full Text] [Related]  

  • 5. Oseltamivir becomes plentiful--but still not cheap.
    Enserink M
    Science; 2006 Apr; 312(5772):382-3. PubMed ID: 16627733
    [No Abstract]   [Full Text] [Related]  

  • 6. Roche Canada stops distributing oseltamivir.
    Spurgeon D
    BMJ; 2005 Nov; 331(7524):1041. PubMed ID: 16269478
    [No Abstract]   [Full Text] [Related]  

  • 7. The Tamiflu tug of war.
    Schwartz ND
    Fortune; 2005 Nov; 152(10):33-4. PubMed ID: 16300366
    [No Abstract]   [Full Text] [Related]  

  • 8. Stockpiling oseltamivir: Roche clarifies data for improved mortality with oseltamivir.
    Smith JR; Dutkowski R
    BMJ; 2005 Nov; 331(7526):1203. PubMed ID: 16293852
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharma industry in India.
    Sundaram VM
    Drug News Perspect; 2008; 21(1):59-63. PubMed ID: 18301810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 11. Indian firm to produce oseltamivir for developing countries.
    Mudur G
    BMJ; 2006 Jan; 332(7532):5. PubMed ID: 16399711
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.